Xoma Series B Preferred Stock

XOMAO

25.52 USD

+0.03

0.12%

At close Updated Dec 12, 4:00 PM EST

1 day

0.12%

5 days

0.28%

1 month

0.31%

3 months

0.2%

6 months

1.07%

Year to date

-0.39%

1 year

0.59%

5 years

3.4%

10 years

3.4%

About: XOMA Royalty Corp is a biotechnology royalty aggregator playing a role in helping biotech companies achieve their goal of improving human health. XOMA acquires the potential future economics associated with pre-commercial therapeutic candidates that have been licensed to pharmaceuticals or biotechnology companies. XOMA acquires future economic rights, the seller receives non-dilutive, non-recourse funding that can use to advance their internal drug candidate(s) or for general corporate purposes. Geographically, the company operates in Switzerland, United States, Asia Pacific, Europe and Others.

Employees: 13

Healthcare Biotechnology

–

Funds holding %

of 7,507 funds

Explore Fund Trends

–

Analysts bullish %

See Analyst Outlook

–

Positive news %

Check Journalist POV